These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 28125604
21. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C. Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358 [Abstract] [Full Text] [Related]
22. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application. Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M. Clin Chim Acta; 2010 Nov 11; 411(21-22):1632-6. PubMed ID: 20542018 [Abstract] [Full Text] [Related]
23. High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease. Djordjević BV, Pavlović R, Ćosić V, Deljanin-Ilić M, Ristić T, Krstić N, Jevtović-Stoimenov T. Amino Acids; 2012 Dec 11; 43(6):2293-300. PubMed ID: 22555650 [Abstract] [Full Text] [Related]
24. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis. Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH. Shock; 2016 Oct 11; 46(4):365-72. PubMed ID: 27206279 [Abstract] [Full Text] [Related]
26. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency. Ronden RA, Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, De Leeuw PW, Kroon AA. Am J Physiol Renal Physiol; 2012 Jul 01; 303(1):F149-56. PubMed ID: 22552932 [Abstract] [Full Text] [Related]
27. Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients. Potočnjak I, Radulović B, Degoricija V, Trbušić M, Pregartner G, Berghold A, Meinitzer A, Frank S. Int J Cardiol; 2018 Jun 15; 261():109-113. PubMed ID: 29550017 [Abstract] [Full Text] [Related]
28. Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010. Desta L, Jernberg T, Spaak J, Hofman-Bang C, Persson H. Eur J Heart Fail; 2016 Jan 15; 18(1):46-53. PubMed ID: 26503670 [Abstract] [Full Text] [Related]
29. Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the Early Detection of Chronic Kidney Disease in Dogs. Nabity MB, Lees GE, Boggess MM, Yerramilli M, Obare E, Yerramilli M, Rakitin A, Aguiar J, Relford R. J Vet Intern Med; 2015 Jan 15; 29(4):1036-44. PubMed ID: 26079532 [Abstract] [Full Text] [Related]
30. Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients. Wnuk Z, Kokot F, Kunsdorf-Wnuk A. Pol Arch Med Wewn; 2012 Jan 15; 122(7-8):367-73. PubMed ID: 22688059 [Abstract] [Full Text] [Related]
31. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease. Hov GG, Aasarød KI, Sagen E, Åsberg A. Clin Biochem; 2015 Jul 15; 48(10-11):646-51. PubMed ID: 25828044 [Abstract] [Full Text] [Related]
32. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania. Atzler D, Schwedhelm E, Nauck M, Ittermann T, Böger RH, Friedrich N. Clin Chem Lab Med; 2014 Dec 15; 52(12):1835-42. PubMed ID: 24945429 [Abstract] [Full Text] [Related]
33. Pro-substance p for evaluation of risk in acute myocardial infarction. Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Struck J, Bergmann A, Maisel A, Jones DJ. J Am Coll Cardiol; 2014 Oct 21; 64(16):1698-707. PubMed ID: 25323258 [Abstract] [Full Text] [Related]
34. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction. Palmer SC, Yandle TG, Frampton CM, Troughton RW, Nicholls MG, Richards AM. Eur Heart J; 2009 Jun 21; 30(12):1486-94. PubMed ID: 19389787 [Abstract] [Full Text] [Related]
35. Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Zairis MN, Patsourakos NG, Tsiaousis GZ, Theodossis Georgilas A, Melidonis A, Makrygiannis SS, Velissaris D, Batika PC, Argyrakis KS, Tzerefos SP, Prekates AA, Foussas SG. Heart; 2012 Jun 21; 98(11):860-4. PubMed ID: 22422591 [Abstract] [Full Text] [Related]
36. Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea. Codognotto M, Piccoli A, Rubini C, Cianci V, Vettore G, Mion MM, Artusi C, Plebani M. Clin Chem Lab Med; 2011 Feb 21; 49(2):237-42. PubMed ID: 21077789 [Abstract] [Full Text] [Related]
37. A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients. Hannemann J, Zink A, Mileva Y, Balfanz P, Dahl E, Volland S, Illig T, Schwedhelm E, Kurth F, Stege A, Aepfelbacher M, Hoffmann A, Böger R. Sci Rep; 2024 Jul 08; 14(1):15739. PubMed ID: 38977837 [Abstract] [Full Text] [Related]
39. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy. Anderssohn M, Rosenberg M, Schwedhelm E, Zugck C, Lutz M, Lüneburg N, Frey N, Böger RH. J Card Fail; 2012 Dec 08; 18(12):904-11. PubMed ID: 23207078 [Abstract] [Full Text] [Related]
40. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R. Minerva Anestesiol; 2010 May 08; 76(5):325-33. PubMed ID: 20395894 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]